The Synthesis and Initial Evaluation of MerTK Targeted PET Agents

MerTK (Mer tyrosine kinase), a receptor tyrosine kinase, is ectopically or aberrantly expressed in numerous human hematologic and solid malignancies. Although a variety of MerTK targeting therapies are being developed to enhance outcomes for patients with various cancers, the sensitivity of tumors t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Zhou, Yubai, Wu, Xuedan, Ma, Xinrui, Li, Bing, Ding, Ransheng, Stashko, Michael A., Wu, Zhanhong, Wang, Xiaodong, Li, Zibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911752/
https://www.ncbi.nlm.nih.gov/pubmed/35268561
http://dx.doi.org/10.3390/molecules27051460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911752/
https://www.ncbi.nlm.nih.gov/pubmed/35268561
http://dx.doi.org/10.3390/molecules27051460

Ejemplares similares